
zzso clinical management of prostate cancer has been zzso by an inadequate understanding of molecular genetic elements governing tumor zzso Gene signatures have provided improved zzso indicators of human prostate zzso The zzso signaling pathway, which zzso zzso transition zzso is known to zzso prostate cancer progression induced by zzso zzso zzso zzso D1 zzso reduced cellular proliferation in the zzso prostate in zzso and in zzso zzso prostate cancer cell zzso The in zzso zzso zzso molecular signature predicted poor outcome of recurrence-free survival for patients with prostate cancer zzso HR, zzso P zzso zzso and demonstrated that zzso zzso D1 zzso zzso zzso zzso and zzso zzso zzso zzso D1 enhanced zzso and zzso cell gene expression and expanded a prostate stem cell zzso In zzso zzso sequencing, zzso D1 occupied genes governing stem cell expansion and induced their zzso The coordination of zzso restraining and stem cell expanding gene expression by zzso D1 in the prostate may contribute to its strong zzso value for poor outcome in zzso recurrence in human prostate zzso 

